Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis

被引:65
作者
Primavera, A
Audenino, D
Mavilio, N
Cocito, L
机构
[1] Univ Genoa, Dept Neurol & Visual Sci, I-16132 Genoa, Italy
[2] Hosp San Martino, Dept Neuroradiol, Genoa, Italy
关键词
D O I
10.1136/ard.60.5.534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives-Reversible posterior leucoencephalopathy syndrome (RPLS) may develop in patients with renal insufficiency, hypertension, and immunosuppression, and is managed by prompt antihypertensive and anticonvulsant treatment. Four patients with renal insufficiency and fluid overload associated with Wegener's granulomatosis tone patient) and systemic lupus erythematosus (SLE) (three patients) are described, whose clinical picture and neuroimaging indicated RPLS. Case reports-All. patients had headache, seizures, visual abnormalities, and transient motor deficit, and were hypertensive at the onset of the symptoms. Head computed tomography (CT) scan and magnetic resonance imaging showed predominantly posterior signal abnormalities, which were more conspicuous on T-2 weighted spin echo images than on CT scan. All patients had some form of cytotoxic treatment shortly before the syndrome developed, and dramatically responded to blood pressure control and anticonvulsant treatment. In two patients with SLE, dialysis was required for renal insufficiency. Discussion-Follow up neuroimaging studies showed almost complete resolution of signal abnormalities, and suggested that RPLS was associated with cerebral oedema without concomitant infarction. The treatment of hypertension and neurotoxic condition such as uraemia appears of primary importance, while immunosuppressive treatment may cause further damage of the blood-brain barrier.
引用
收藏
页码:534 / 537
页数:4
相关论文
共 15 条
[1]  
Arai M, 1997, Rinsho Shinkeigaku, V37, P64
[2]   Posterior leukoencephalopathy without severe hypertension - Utility of diffusion-weighted MRI [J].
Ay, H ;
Buonanno, FS ;
Schaefer, PW ;
Le, DA ;
Wang, B ;
Gonzalez, RG ;
Koroshetz, WJ .
NEUROLOGY, 1998, 51 (05) :1369-1376
[3]   Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: Magnetic resonance imaging findings [J].
Bakshi, R ;
Bates, VE ;
Mechtler, LL ;
Kinkel, PR ;
Kinkel, WR .
EPILEPSIA, 1998, 39 (03) :295-299
[4]   Erythropoietin-associated hypertensive posterior leukoencephalopathy [J].
Delanty, N ;
Vaughan, C ;
Frucht, S ;
Stubgen, P .
NEUROLOGY, 1997, 49 (03) :686-689
[5]   Posterior leucoencephalopathy syndrome [J].
Donnan, GA .
LANCET, 1996, 347 (9007) :988-988
[6]  
Eaton JM, 1996, NEW ENGL J MED, V334, P1744
[7]   A reversible posterior leukoencephalopathy syndrome [J].
Hinchey, J ;
Chaves, C ;
Appignani, B ;
Breen, J ;
Pao, L ;
Wang, A ;
Pessin, MS ;
Lamy, C ;
Mas, JL ;
Caplan, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500
[8]   Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction [J].
Ito, Y ;
Niwa, H ;
Iida, T ;
Nagamatsu, M ;
Yasuda, T ;
Yanagi, T ;
Sobue, G .
NEUROLOGY, 1997, 49 (04) :1174-1175
[9]  
Ito Y, 1998, AM J NEURORADIOL, V19, P415
[10]   Cyclosporine-related reversible posterior leukoencephalopathy: MRI [J].
Jarosz, JM ;
Howlett, DC ;
Cox, TCS ;
Bingham, JB .
NEURORADIOLOGY, 1997, 39 (10) :711-715